Publications & Resources

The Wrinkles That Botox Causes for Dentists: Case Study and Unique Risks

For dentists, Botox can cause wrinkles. Here’s a case study involving the use of Botox in dentistry and a deep dive into the unique risks that Botox can pose for dental professionals.

The Risks of Offering Botox in Dentistry: A Legal Perspective

In the increasingly competitive profession of dentistry, dentists search for an edge to set them apart. Botox is marketed as a way to increase patient traffic to the dental office. However, the use of Botox in dentistry carries additional risks that dentists should know about.

Discussing Dietary Supplements with Patients

Given the vast array of dietary supplements on the market—some of which may be ineffective or potentially harmful—it’s more important than ever to discuss these products with patients.

Individualized Opioid Interventions Can Reduce Use After Surgery

Experts say patient-centric opioid intervention before discharge from the hospital can cut overall opioid intake, while still ensuring a patient is satisfied and their pain is properly managed.

FDA Issues EUA for Monoclonal Antibody Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization for simultaneous administration of monoclonal antibodies bamlanivimab and etesevimab to treat COVID-19 patients who meet specific criteria.

FDA Issues Alert on SARS-CoV-2 Viral Mutations and the Associated Impact on Testing

The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.

FDA Publishes AI/ML-Based Software as a Medical Device Action Plan

The U.S. Food and Drug Administration released an AI/ML-Based Software as a Medical Device Action Plan, which outlines a detailed approach to ensuring the safety and efficacy of these technologies.

FDA Cautions Use of Face Masks with Metal During MRIs Poses Patient Safety Risk

The U.S. Food and Drug Administration cautions that patients can be injured if wearing face masks with metal features or coating during an MRI exam.

FDA Grants an EUA for Bamlanivimab to Treat COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has granted Eli Lilly and Company an emergency use authorization for bamlanivimab to treat mild-to-moderate COVID-19 in adult and pediatric patients.

FDA Approves Veklury for Treatment of COVID-19 Patients Who Meet Certain Criteria

The U.S. Food and Drug Administration has approved the antiviral drug remdesivir, sold as Veklury, to treat COVID-19 patients who meet specific criteria.